IMMU-52. SELECTION OF GLIOMA T-CELL THERAPY TARGETS BASED ON THE ANALYSIS OF TUMOR IMMUNOPEPTIDOME AND EXPRESSION PROFILES

Diffuse infiltrating low-grade gliomas (WHO grade II or III) are slow-growing primary brain tumors, but are considered malignant due to their invasive growth with a high risk of recurrence and progression to higher-grade tumors. While novel immunotherapeutic approaches are being developed, the pauci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Carrera, Diego, Hayes, Josie, Mueller, Soeren, Shelton, Samuel J, Weinschenk, Toni, Song, Colette, Fritsche, Jens, Schoor, Oliver, Kuttruff-Coqui, Sabrina, Hilf, Norbert, Kohanbash, Gary, Watchmaker, Payal, Oldham, Michael C, Costello, Joseph, Singh, Harpreet, Okada, Hideho
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693081/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.510
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados